Media MICE

Media MICE Content Marketing - Advertising - Medical Writing Founded in 2009, Media MICE is an integrated marketing agency currently based in Singapore. We’re young.

Starting out small, we have since grown to a team comprising writers, designers, marketers, strategists and innovators. We believe in providing customized solutions and delivering quality content that helps to set you apart from your clients. In this dynamic and competitive landscape, we’re your best bet in formulating a brilliant marketing plan. Our area of expertise includes content marketing, creative events and medical publishing. We’re innovative. We’re passionate about what we do. Drop us an email at [email protected] to work with us.

Five decades of surgeon-driven innovation. One big thank-you to the people who made it possible.MST is hitting 50 years🎉...
04/10/2026

Five decades of surgeon-driven innovation. One big thank-you to the people who made it possible.

MST is hitting 50 years🎉To celebrate, they’re saying thanks with $50 off select new products, including…

-ArcDUO™
-19g Fram/Ayres IOL Cutter
-Volk GonioPro® Surgical Suite.

Take note, the offer runs through October 31, 2026.

Heading to AAO 2026 in New Orleans? Stop by Booth #737 to connect with the team and see what’s new.

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

MST - MicroSurgical Technology

For four days, the Media MICE team scurried between lecture theaters and booths, chasing stories and running on Viennese...
04/10/2026

For four days, the Media MICE team scurried between lecture theaters and booths, chasing stories and running on Viennese coffee.

Thank you to every delegate and booth neighbor who stopped by D57, claimed their spot on our world map and grabbed a copy of PIE 39. Vienna, consider yourself imprinted on our retinas.

Next stop, .

Day 3 at was a day for second opinions, from a VUS that badly needed one to five expert panels putting retina's toughe...
04/10/2026

Day 3 at was a day for second opinions, from a VUS that badly needed one to five expert panels putting retina's toughest calls to a vote. Here's who weighed in.

-WSPOS x Euretina 2026: In Pediatric Retina, Look Twice Before You Act: A variant of uncertain significance that turned out to be likely pathogenic, a cone dystrophy panel that pulled a whole family into testing, and a sober look at where XLRS treatment really stands. https://mediamice.com/wspos-x-euretina-2026-in-pediatric-retina-look-twice-before-you-act/

-Retina Goes to the Polls: APVRS Consensus at Euretina 2026: Five APVRS panels, a 75% threshold and a unanimous vote that drusen-free Asian eyes can still have nAMD. The statements that stalled may make the best research leads of all. https://mediamice.com/apvrs-consensus-retinal-diseases-euretina-2026/

-Retinal Innovation: Gene Therapy Meets EU Policy at Euretina 2026: Chorioretinal atrophy in roughly 40% of Luxturna patients (with better sensitivity gains in those who developed it), a CEP290 trial nearly sunk by its own design, and a Europe of 27 member states still trying to run trials as one. https://mediamice.com/euretina-2026-gene-therapy-eu-policy-retinal-innovation/

Like a proper Wiener Melange, Day 3 poured very different views into one cup and came out smoother for it.

The rest of Day 3 is waiting here: https://mediamice.com/auf-wiederschauen-viennathats-a-wrap-euretina-2026/

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

EURETINA

Day 2 at was a lesson in not taking anything at face value: not floaters, not reattached retinas and not algorithms th...
03/10/2026

Day 2 at was a lesson in not taking anything at face value: not floaters, not reattached retinas and not algorithms that look great on paper. Three sessions did the unmasking.

—Retinal Disease Masquerades: Diagnostic Traps on Spotlight: Five questions to ask before calling a floater age-related, a standing order to always check the periphery, and a live four-case quiz that nobody in the room aced. https://mediamice.com/euretina-2026-retinal-disease-masquerades-diagnostic-traps/

—Reattached Is Not Restored: Retinal Detachment Evidence: Prof. David Steel brought a 19,000-case registry showing gas tamponades holding their own against oil, and Prof. Noemi Lois pressed on why a reattached retina so often falls short on vision. https://mediamice.com/retinal-detachment-evidence-euretina-2026/

—Beyond the Snapshot: Imaging and AI Rethink Diabetic Retinopathy at Euretina 2026: Prof. Stela Vujosevic made the case that acuity charts miss too much, and Prof. Adnan Tufail reminded the room that an impressive algorithm still has to survive an ordinary clinic day. https://mediamice.com/imaging-ai-diabetic-retinopathy-euretina-2026/

Meanwhile, the exhibition floor kept waltzing, with Astellas Pharma, Roche, Lumibird Medical and Appasamy Associates among the partners.

Here's Day 2's full dance card, with plenty more to come before the music stops: https://mediamice.com/retinas-masquerade-ball-day-2-euretina-2026/

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

EURETINA

You map the macula every day. At Booth , we've got a bigger map for you (no OCT required). Find your city, pin it and a...
02/10/2026

You map the macula every day. At Booth , we've got a bigger map for you (no OCT required). Find your city, pin it and add a sticky note with your biggest challenge in eye care. Venting is allowed.

Tag the colleague at who definitely has opinions and bring them by to claim their spot. Snap it, share it and tag .

Don't miss out! Be sure to grab a fresh copy of PIE 39 while at our booth.

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore

EURETINA

02/10/2026

Every cataract surgeon has that one IOL they keep coming back to. The interesting question is: why?

Watch as Centre For Sight Eye Hospitals’ Chairman & Medical Director, Padma Shree Awardee, Prof. Dr. Mahipal S. Sachdev, shares why the RayOne Galaxy Spiral IOL has earned a place in his routine practice. From its AI-designed, non-diffractive spiral optic to the visual outcomes he’s seeing in patients pursuing spectacle independence, he explains what has stood out in real-world use, and why ease of implantation matters just as much as optical performance.

Visit www.galaxyiol.com for more information.

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

Rayner India

Day 1 at had dry AMD reaching for the moon, retinas moonlighting as cardiology screens, and proteins filling in what t...
01/10/2026

Day 1 at had dry AMD reaching for the moon, retinas moonlighting as cardiology screens, and proteins filling in what the OCT leaves out.

Here's where the thinking happened (each worth a tap):

—Retinal Clues to Systemic Disease: Amyloid posing as uveitis, drug toxicity that hides from the angiogram and a pale teenager whose blood work told the real story. Required reading for anyone tempted to stop at the fundus. https://mediamice.com/euretina-2026-retinal-clues-systemic-disease/

—Beyond the Scan: Retinal Biomarkers, AI and Imaging: A protein called afamin, AI built without an engineer in sight, and “digital histology” sharp enough to stand in for a biopsy. Plus one silicone oil complication still waiting on a definition. https://mediamice.com/beyond-the-scan-retinal-biomarkers-ai-euretina-2026/

—Frank Holz Lights Up Dry AMD's Dark Side: Wet AMD got its revolution in 2006. At the Opening Ceremony, Prof. Frank Holz mapped three horizons for the dry side, from slowing atrophy to a photovoltaic retinal chip that earned its CE mark in July. https://mediamice.com/frank-holz-dry-amd-three-horizons-euretina-2026/

A very Viennese day, with sunshine outside, a moon landing inside and almost 11,000 delegates in between.
Everything from Day 1 in one place, with plenty more to come: https://mediamice.com/euretina-2026-day-1-waking-up-to-sayhallo-vienna/

EURETINA

Somewhere in Vienna, delegates from more than 140 nationalities are all talking about the exact same thin layer of tissu...
01/10/2026

Somewhere in Vienna, delegates from more than 140 nationalities are all talking about the exact same thin layer of tissue at the back of the eye.

is the largest retina meeting in the world, which makes it an excellent place to find out how many ways there are to disagree about it (politely, mostly). The Media MICE team is darting between session halls and the exhibition floor to bring you the latest science and the hottest news.

Stick with us for live coverage, key takeaways and the hallway buzz.

Oh, and don’t forget to stop by our booth ( ) to grab a fresh copy of PIE 39, hot off the press.

EURETINA

01/10/2026

⏰ Our Euretina 2026 Masterclass is almost here! Don't miss it.

🗓️ Friday, Oct 2 · 2:30 PM
📍 OD-OS Navilas® · Booth E24

Dr. Maximilan Hammer: Getting Started with Navilas®:
Our Training Concept and Clinical Case Examples from University Hospital Heidelberg

Discover how Navilas® fits into daily clinical practice through real cases presented by experienced Navilas® users. You’ll also see a live system demo and have the chance to ask your questions during the Q&A.

You can't miss us. Just spot the OD-OS green. 👀💚

See you at Booth E24!

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

OD-OS Navilas

Vienna, you’re up next. Fresh off their European debut at ESCRS, MacuMira is bringing their dry AMD story to Euretina 20...
30/09/2026

Vienna, you’re up next.

Fresh off their European debut at ESCRS, MacuMira is bringing their dry AMD story to Euretina 2026, with global partner Keeler along for the ride.

Swing by Booth D17 from October 1–4 to:
• Catch the MacuMira device in action with a live demo
• Dig into their growing body of clinical and real-world evidence
• Find out what’s behind the technology and how it aims to support visual function in dry AMD
• Meet the leadership team (Matt Van de Ven, Rob Crate and Muhammad Muhammad) and hear what they have planned for Europe

With more than 35,000 treatments performed worldwide, they’ve got plenty to talk about. Pop by between sessions (and Sachertorte breaks).

📍 Euretina 2026 | VIECON
📅 October 1–4, 2026
🏷️ MacuMira Booth D17

Rather skip the booth crowd? Book a one-on-one with the MacuMira team: https://calendly.com/d/dtdj-y62-k67

MacuMira is not currently CE marked. For presentation and demonstration purposes only. Not available on the EU or UK market until brought into compliance with Regulation (EU) 2017/745.

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

#

Address

6001 Beach Road, #09-09 Golden Mile Tower
Singapore
199589

Website

,

Alerts

Be the first to know and let us send you an email when Media MICE posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Media MICE:

Shortcuts

Share

Category